Yifan Pharmaceutical Co., Ltd.

符号: 002019.SZ

SHZ

11.4

CNY

今天的市场价格

-33.8207
市盈率
0.4747
PEG比率
13.89B
MRK市值
0.00%
DIV收益率

Yifan Pharmaceutical Co., Ltd. (002019-SZ) 财务报表

Q: 什么是 Yifan Pharmaceutical Co., Ltd. (002019.SZ) 总资产是多少？

Yifan Pharmaceutical Co., Ltd. (002019.SZ) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Yifan Pharmaceutical Co., Ltd. (002019.SZ). 的默认数据。公司收入显示 1939.694 M 的平均值，即 0.195 % 增长率。整个期间的平均毛利润为 878.093 M，即 0.300 %. 平均毛利率为 0.392 %. 公司去年的净收入增长率为 -5.334 %，等于 6.657 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Yifan Pharmaceutical Co., Ltd. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 -0.083. 在流动资产领域，002019.SZ 的报告货币为3251.143. 这些资产中的很大一部分，即 773.378 是现金和短期投资。与去年的数据相比，该部分的变化率为-0.376%. 公司的长期投资虽然不是其重点，但以报告货币计算的718.463（如果有的话）为718.463。这表明与上一报告期相比，19.508% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 812.043. 这一数字表明，-0.077% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 8275.634. 这方面的年同比变化率为 -0.061%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为1390.536，存货估值为 928.61，商誉估值为 2737.42（如有. 无形资产总额（如果有）按 2605.59 估值. 应付账款和短期债务分别为 431.36 和 1116.42. 债务总额为1995.19，债务净额为 1296.82. 其他流动负债为 506.35，加上总负债 3144.93. 最后，如果存在推荐股票，则其估值为 0.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
balance-sheet.row.cash-and-short-term-investments	3477.57	773.4	1239.3	1336.1	1370.5	1562.7	1637.4	1308.9	729.5	332.2	277.7	124.2	125.8	145.1	156.1	228.5	51.1	96.3	69.6	46.5	101.6	8.6	21.4	14.2
balance-sheet.row.short-term-investments	345.01	75	95.5	-62.1	46.7	39	10.1	-67.8	-70.9	-13.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	5608.97	1390.5	1527.3	1391	1348.4	1230.6	1360.6	1202.2	1055.9	746.1	645.1	225.2	233.4	164.4	140.4	172.1	126.5	224.6	109	79.1	52.7	44.4	23.2	18.4
balance-sheet.row.inventory	3879.32	928.6	831	663.9	583.9	598.2	477.8	392.2	376.5	368.5	283.2	147.6	153.8	173.4	122.1	88.9	115.1	79.5	45.9	58.4	35.6	21	19	11.8
balance-sheet.row.other-current-assets	637.11	158.6	92.4	194.5	203.4	128.8	219.6	750.4	248.6	72.1	18.3	-2.9	-4	-8.8	-10.1	-4.9	-7.4	-4.2	4.9	2.6	2.2	5.9	3.4	0.9
balance-sheet.row.total-current-assets	13602.98	3251.1	3689.9	3585.5	3506.1	3520.3	3695.5	3653.7	2410.5	1519	1224.3	494.1	509.1	474.1	408.6	484.6	285.2	396.3	229.4	186.6	192.2	79.9	67.1	45.3
balance-sheet.row.property-plant-equipment-net	6805.25	1811.8	1601.4	1642.8	1454.2	1240.4	1076.3	887.8	820	838.5	672.7	504.6	487.1	526.4	573.8	494.9	411.7	346.4	275.9	249.6	165.8	118.1	64	41.1
balance-sheet.row.goodwill	10950.38	2737.4	2737.8	2737.8	2749.7	2727.7	2645.2	2413.3	2394.5	1819	1242.7	0	0	0	39.9	65.1	65.1	65.1	3.2	3.6	0	0	0	0
balance-sheet.row.intangible-assets	12107.43	2605.6	3298.7	3091.4	2869.2	2583.6	2018.7	1466.6	1211.9	232	144.4	60	62.4	84.8	88.1	77	72.6	58	18.6	10.9	0.8	0.8	0.9	1
balance-sheet.row.goodwill-and-intangible-assets	23057.8	5343	6036.5	5829.2	5618.8	5311.3	4663.9	3879.9	3606.5	2051.1	1387.1	60	62.4	84.8	128	142.1	137.7	123.1	21.8	14.4	0.8	0.8	0.9	1
balance-sheet.row.long-term-investments	2619.46	718.5	601.2	702.2	619.5	668.1	33.7	118	80.7	16.3	2	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	1129.77	257.8	290.8	244.4	226.3	163.6	126.6	83.4	49.4	29.8	25.4	0	0	0	0	4.9	2.6	2.3	1.6	0	0	0	0	0
balance-sheet.row.other-non-current-assets	992.6	117.4	323.7	161	212.3	162.1	179	145	16.4	92.1	23.3	2.4	2.9	81	91	14	19	16.4	53.7	66.4	0	0.2	0	0
balance-sheet.row.total-non-current-assets	34604.87	8248.4	8853.6	8579.6	8131.2	7545.5	6079.4	5114	4573	3027.7	2110.4	566.9	552.4	692.2	792.9	655.9	571.1	488.1	353	330.3	166.5	119.1	64.9	42.1
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	48207.85	11499.6	12543.5	12165.1	11637.2	11065.8	9774.9	8767.7	6983.5	4546.7	3334.7	1061	1061.5	1166.3	1201.4	1140.5	856.3	884.4	582.4	516.9	358.7	199	132	87.4
balance-sheet.row.account-payables	1628.12	431.4	288.4	350.9	381.2	419	417	251.2	411.9	326.1	301.9	93.6	103.7	98.7	51.4	30.9	26	24.4	32.3	18.2	7.7	16.8	5.6	5.2
balance-sheet.row.short-term-debt	4633.39	1116.4	1231.2	1438.9	1211.2	1826.8	1464.3	938.6	1380.5	736.9	292.5	416.7	455.7	546	350	170	225	209	218	143	23	50.4	44.4	29.4
balance-sheet.row.tax-payables	219.64	19.1	107.5	82.6	78	115.3	130.9	146.7	153.4	73.2	60.1	-12	-17.8	-26.7	-21.1	0.8	8.3	84.7	4.8	9	0.8	-3	-7.6	-3
balance-sheet.row.long-term-debt-total	3295.67	812	930.9	820.3	447.6	84	32.2	124	180	30	0	0	0	0	80	0	0	0	0	0	0	30	0	0
Deferred Revenue Non Current	397.93	99.7	104.8	85.7	80.3	43.5	29.2	23.9	23.2	19.5	17.2	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	383.83	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	1089.05	506.4	476.5	7.5	13	69.1	384	64.2	138.9	102.7	25	5.7	4.3	3.3	3.1	2	9.5	3.6	0.6	1.3	0.9	9.7	10.1	0.4
balance-sheet.row.total-non-current-liabilities	4200.61	957.6	1197.9	1088.7	778.1	360.8	491	398.8	514.5	237.7	34.4	17.2	2.5	7.8	88.7	7.3	0	0.2	0.4	0	2.2	30.8	0	0
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	269.78	66.7	80.7	89.8	72.6	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	12952.29	3144.9	3397.3	3390.6	2907	3244.1	2887.2	1985.5	3082.9	1666.2	791.2	553.3	580.7	696.7	497.8	227.3	285.4	335.9	267.9	196	48.7	104.7	52.5	35.1
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	4185.27	1046.3	1046.3	1054.4	1055	1057.2	1027.3	1027.3	921.1	260.6	260.6	220.4	220.4	220.4	220.4	220.4	191.1	191.1	68.3	68.3	52.5	37.5	37.5	21.9
balance-sheet.row.retained-earnings	18318.97	4204.1	4754.6	4562.1	4354.8	3509.8	2741.8	2496.3	1353	713	420.1	-105	-130.6	-144.9	85.4	305	296.7	278.3	70.2	78.7	70.7	43	32.3	25.7
balance-sheet.row.accumulated-other-comprehensive-income-loss	6739.51	200.9	27.2	76.4	184.6	74.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	5406.71	2824.4	2983.4	2842.3	2845.5	2858.1	2854.9	2944.9	1250.5	1884.4	1863.4	392.2	391	391	389.8	387.8	83	79.2	175.9	173.1	186.8	13.8	9.6	4.7
balance-sheet.row.total-stockholders-equity	34650.46	8275.6	8811.5	8535.2	8439.9	7499.6	6623.9	6468.5	3524.6	2858.1	2544.2	507.6	480.8	466.5	695.6	913.1	570.9	548.5	314.4	320.1	310	94.3	79.4	52.3
balance-sheet.row.total-liabilities-and-stockholders-equity	48207.85	11499.6	12543.5	12165.1	11637.2	11065.8	9774.9	8767.7	6983.5	4546.7	3334.7	1061	1061.5	1166.3	1201.4	1140.5	856.3	884.4	582.4	516.9	358.7	199	132	87.4
balance-sheet.row.minority-interest	505.36	-20.7	334.8	239.4	290.4	322.1	263.7	313.8	376	22.5	-0.7	0	0	3	8	0	0	0	0	0.8	0	0	0	0
balance-sheet.row.total-equity	35155.81	8254.9	9146.2	8774.6	8730.2	7821.7	6887.7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	48207.85	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	2964.47	793.5	696.7	640.1	666.2	707.1	43.7	50.2	9.8	2.8	2	0	0	77.8	87.6	10.8	15.9	13.5	53.5	64.8	0	0	0	0
balance-sheet.row.total-debt	8055.08	1995.2	2162.1	2259.2	1658.9	1910.7	1496.5	1062.6	1560.5	766.9	292.5	416.7	455.7	546	430	170	225	209	218	143	23	80.4	44.4	29.4
balance-sheet.row.net-debt	4922.52	1296.8	1018.3	923.1	335.1	387.1	-130.8	-246.2	831	434.6	14.8	292.5	329.8	400.9	273.9	-58.5	173.9	112.7	148.4	96.5	-78.6	71.7	23	15.2

现金流量表

在 Yifan Pharmaceutical Co., Ltd. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -1.154 的转变。该公司最近通过发行 0.85 扩大了股本，与上一年相比出现了0.000 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-670165050.310. 与上一年相比， 0.320 发生了变化. 在同一时期，公司记录了 228.43, 6.46 和 -1880.31，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-86.38 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 2006.74，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003
cash-flows.row.net-income	-469.75	127.2	242.2	931.4	873.1	693.7	1265.7	683.4	362	237.9	25.6	11.3	-236.8	-201.5	30.4	41.2	240.2	1.9	20.5	32.5	25.9
cash-flows.row.depreciation-and-amortization	18.71	228.4	207.2	177	153.7	121.5	106.5	87.3	71.1	21.7	52.8	51.3	43.2	40.6	36.1	32.8	25.3	32.1	32.6	23.5	14.6
cash-flows.row.deferred-income-tax	0	-53.9	-87	-33.4	-44.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	53.9	-7	82.8	47.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-97.84	-168.2	-285.4	-178.5	-275.1	226.2	-407.9	18.6	-79.8	-131.5	-14.4	-45.9	-61.2	-41.6	-17.8	-16.3	-32	-19.5	-39.3	-23.9	-30.7
cash-flows.row.account-receivables	-10.25	-103.8	-18.6	-117.7	-58	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-109.39	-167.1	-80.5	21.9	-113.5	-7	-17.3	-8	-56.1	-26.5	0.5	11.5	-58.1	-37	26.5	-37.6	-38.4	10.7	-23.8	-25	-12.4
cash-flows.row.account-payables	0	156.6	-99.3	-49.2	-59.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	21.79	-53.9	-87	-33.4	-44.5	233.2	-390.7	26.6	-23.7	-105.1	-14.8	-57.4	-3.1	-4.7	-44.2	21.3	6.4	-30.1	-15.4	1.1	-18.3
cash-flows.row.other-non-cash-items	1043.98	284.7	231.3	129.2	182.3	129.5	168.5	66.5	48.7	11.6	38	13.1	202	168.7	9.9	25.5	15.3	18.1	10.3	1.4	2.9
cash-flows.row.net-cash-provided-by-operating-activities	495.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-516.29	-542.3	-571.7	-715.7	-866.1	-729.2	-485.9	-287.5	-217.2	-89.5	-73.9	-67.6	-99.7	-199.3	-151.3	-122.5	-172.1	-57.6	-58.6	-70.1	-52.4
cash-flows.row.acquisitions-net	11.1	1.2	-26.1	-36.8	-818.8	-449.1	-506.7	-599.1	-563	-52.5	154.9	31.2	0	1.5	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	-1437.41	-1253.6	-1265	-1141	-922.9	-825.5	-2151.2	-687.8	-445	-217.5	-153	42	0	-80	0	0	-12	-10.2	-92.6	0	0
cash-flows.row.sales-maturities-of-investments	1404.08	1118	1337.2	1122	1020.5	1386.6	1586.4	539.7	395.9	258.8	10	56.6	41.3	9	6	0	0	0	0	0	0
cash-flows.row.other-investing-activites	-349.06	6.5	17.7	1	0.8	0.7	2	3.3	1.4	65.5	12.2	4	5	2.5	4.3	8.8	1.4	0.6	18.5	-14.9	3.2
cash-flows.row.net-cash-used-for-investing-activites	-538.51	-670.2	-507.9	-770.6	-1586.5	-616.5	-1555.4	-1031.5	-827.9	-35.2	-49.8	66.2	-53.5	-266.4	-141	-113.7	-182.6	-67.2	-132.8	-85	-49.3
cash-flows.row.debt-repayment	-754.5	-1880.3	-2432.7	-2210	-2069	-1820.3	-1746.5	-1116.9	-818.8	-126.8	-545.7	-586	-434.1	-230	-290	-219	-235	-143	-98	-102.6	-46.2
cash-flows.row.common-stock-issued	0	0.8	1	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	-38	-53.6	-121.5	-1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-68.79	-86.4	-138.4	-202	-192.3	-543.5	-176.4	-96.7	-65.4	-6.2	-28	-32.2	-28	-38.7	-29.1	-32.4	-30.4	-20.3	-16.7	-3.5	-15.6
cash-flows.row.other-financing-activites	569.44	2006.7	2913.7	1844	2412.4	2117	3007.2	1877.9	1298.1	140	528.3	462.7	550.1	496.5	566	235	226	221	185.7	233	85.6
cash-flows.row.net-cash-used-provided-by-financing-activities	-78.12	-12.7	222.2	-567.9	151.1	-246.7	1084.4	664.3	413.9	7	-45.4	-155.6	88	227.8	246.9	-16.4	-39.4	57.7	71	126.9	23.8
cash-flows.row.effect-of-forex-changes-on-cash	16.15	59.6	-20.9	1.3	9.6	-3	-23.1	-12.6	-5.2	-2.6	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-45.08	-151.2	-5.4	-228.7	-488.5	304.7	638.6	476	-17.2	109	6.8	-59.5	-18.3	-72.4	164.5	-46.8	26.7	23.1	-37.6	75.5	-12.8
cash-flows.row.cash-at-end-of-period	3004.74	711.6	862.8	868.2	1096.8	1585.4	1280.7	642.1	166.1	183.4	70.7	63.9	123.4	141.7	214.1	49.6	96.3	69.6	46.5	84.1	8.6
cash-flows.row.cash-at-beginning-of-period	3049.83	862.8	868.2	1096.8	1585.4	1280.7	642.1	166.1	183.4	74.4	63.9	123.4	141.7	214.1	49.6	96.3	69.6	46.5	84.1	8.6	21.4
cash-flows.row.operating-cash-flow	495.1	472.1	301.2	1108.5	937.2	1170.9	1132.7	855.8	402	139.7	102	29.9	-52.8	-33.8	58.6	83.3	248.7	32.6	24.1	33.6	12.7
cash-flows.row.capital-expenditure	-516.29	-542.3	-571.7	-715.7	-866.1	-729.2	-485.9	-287.5	-217.2	-89.5	-73.9	-67.6	-99.7	-199.3	-151.3	-122.5	-172.1	-57.6	-58.6	-70.1	-52.4
cash-flows.row.free-cash-flow	-21.2	-70.2	-270.5	392.8	71.2	441.7	646.9	568.3	184.8	50.2	28.1	-37.8	-152.6	-233.1	-92.7	-39.2	76.6	-25	-34.5	-36.6	-39.8

利润表行

Yifan Pharmaceutical Co., Ltd. 的收入与上期相比变化了 0.048%。据报告, 002019.SZ 的毛利润为 1830.89。该公司的营业费用为 1821.44，与上年相比变化了 19.441%. 折旧和摊销费用为 228.43，与上一会计期间相比变化了 0.225%. 营业费用报告为 1821.44，显示19.441% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长-0.976%. 营业收入为 9.45，与上年相比变化了-0.976%. 净利润的变化率为 -5.334%。去年的净收入为-551.07.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
income-statement-row.row.total-revenue	4433.29	4022.2	3836.6	4409	5400.4	5186.8	4631.8	4373.3	3504.6	2434.9	1685	698	644.2	495.7	379.9	406	479.9	764.7	346.4	269.3	245.1	176.8	130.9	91.3
income-statement-row.row.cost-of-revenue	2354.45	2191.3	1970.7	2580.7	2890.5	2794.1	2590.2	1870.3	1733.1	1451.4	1012.5	501.9	497.4	386.7	280.6	270.4	278	275.5	225	188.7	164.2	121.1	87.7	54.8
income-statement-row.row.gross-profit	2078.84	1830.9	1865.9	1828.4	2509.9	2392.7	2041.6	2503	1771.5	983.5	672.5	196.1	146.8	109	99.3	135.6	201.9	489.2	121.5	80.6	80.8	55.6	43.2	36.5
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	320.03	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	115.55	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	1184.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-859.52	-26.3	161.9	248.2	133.1	190.6	-8.3	23.8	8.7	72	2.6	3	16.6	1.9	2.8	6.5	1	-1.3	0.5	0.8	0.8	3	5.2	0
income-statement-row.row.operating-expenses	2783.92	1821.4	1525	1476.3	1335.6	1197.9	1052.1	839.4	796.1	575	366.6	131.2	126.1	139.2	122.2	95.4	128.1	116.5	96.7	43.2	40.6	23.3	16.6	9.8
income-statement-row.row.cost-and-expenses	5138.37	4012.7	3495.7	4057	4226.1	3992	3642.3	2709.7	2529.1	2026.5	1379.1	633.1	623.5	525.9	402.8	365.8	406.1	392.1	321.7	231.9	204.8	144.4	104.3	64.6
income-statement-row.row.interest-income	16.25	13.1	21.4	25.3	26.3	20.7	46.7	13	5	5.8	5	1.9	5.1	2.2	2.5	0	0	0	0.4	0.8	0.4	0.1	0.1	0
income-statement-row.row.interest-expense	71.66	75.6	85.8	74.6	71.1	70.4	61.8	67.5	54.8	21.8	4.6	28.2	32.1	29	16.3	7	13.1	20.2	10.2	6.2	1.4	3.3	1.8	1.6
income-statement-row.row.selling-and-marketing-expenses	1184.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	55.19	-859.2	-242.6	-137.8	-3.8	-7.9	-104.6	-133.3	-80.8	35.9	-4.5	-37.8	-8.9	-206	-171.7	-5	-24.9	-24	-19.6	-13.1	-2	-1.1	3	-1.8
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-859.52	-26.3	161.9	248.2	133.1	190.6	-8.3	23.8	8.7	72	2.6	3	16.6	1.9	2.8	6.5	1	-1.3	0.5	0.8	0.8	3	5.2	0
income-statement-row.row.total-operating-expenses	55.19	-859.2	-242.6	-137.8	-3.8	-7.9	-104.6	-133.3	-80.8	35.9	-4.5	-37.8	-8.9	-206	-171.7	-5	-24.9	-24	-19.6	-13.1	-2	-1.1	3	-1.8
income-statement-row.row.interest-expense	71.66	75.6	85.8	74.6	71.1	70.4	61.8	67.5	54.8	21.8	4.6	28.2	32.1	29	16.3	7	13.1	20.2	10.2	6.2	1.4	3.3	1.8	1.6
income-statement-row.row.depreciation-and-amortization	248.89	279.8	228.4	207.2	273.6	326.1	121.5	106.5	87.3	71.1	21.7	52.8	51.3	43.2	40.6	36.1	32.8	25.3	32.1	32.6	23.5	14.6	6.7	1.3
income-statement-row.row.ebitda-caps	-554.16	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-800.46	9.5	399.4	348.6	1084.6	1076	891.1	1506.4	899.5	377.2	299.3	25.3	-3.2	-230.1	-186.9	30.1	55.6	350.3	7.4	26.2	39.9	29.5	25	25.7
income-statement-row.row.income-before-tax	-745.27	-849.8	156.7	210.8	1080.7	1068.2	884.9	1530.2	894.6	444.3	301.4	27.1	11.8	-236.2	-194.7	35.2	48.9	348.7	6.5	25.7	39.5	31.9	29.9	25.3
income-statement-row.row.income-tax-expense	56.73	16.6	29.6	-31.4	149.3	195.1	191.2	264.6	211.3	82.4	63.5	1.4	0.5	0.7	6.9	4.9	7.6	108.5	4.6	5.1	7	6	3.8	0.6
income-statement-row.row.net-income	-469.75	-551.1	127.2	278.4	968.4	903.5	737.4	1305.1	704.8	360.6	237.9	25.6	14.3	-230.3	-197.6	30.4	41.2	240.2	1.9	20.5	32.5	25.9	26.1	24.7